Anidulafungina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anidulafungina" in Polish language version.

refsWebsite

Global rank Polish rank

9doi.org

2^nd place

6^th place

9nih.gov

4^th place

7^th place

1drugbank.ca

4,294^th place

205^th place

doi.org

dx.doi.org

H.H. Hof H.H., A.A. Dietz A.A., Antifungal activity of anidulafungin, a product of Aspergillus nidulans, against Aspergillus nidulans, „International Journal of Antimicrobial Agents”, 33 (3), 2009, s. 285–286, DOI: 10.1016/j.ijantimicag.2008.08.022, PMID: 19026523 [dostęp 2024-05-05] (ang.).
M.A.M.A. Pfaller M.A.M.A. i inni, In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole, „Journal of Clinical Microbiology”, 43 (11), 2005, s. 5425–5427, DOI: 10.1128/JCM.43.11.5425-5427.2005, PMID: 16272464, PMCID: PMC1287823 [dostęp 2024-05-05] (ang.).
Annette C.A.C. Reboli Annette C.A.C. i inni, Anidulafungin versus fluconazole for invasive candidiasis, „The New England Journal of Medicine”, 356 (24), 2007, s. 2472–2482, DOI: 10.1056/NEJMoa066906, PMID: 17568028 [dostęp 2024-05-05] (ang.).
Melissa J.M.J. Jacobson Melissa J.M.J. i inni, In vitro activity of anidulafungin against Candida albicans biofilms, „Antimicrobial Agents and Chemotherapy”, 52 (6), 2008, s. 2242–2243, DOI: 10.1128/AAC.00211-08, PMID: 18391031, PMCID: PMC2415795 [dostęp 2024-05-05] (ang.).
BharatB. Damle BharatB., MartinM. Stogniew MartinM., JamesJ. Dowell JamesJ., Pharmacokinetics and tissue distribution of anidulafungin in rats, „Antimicrobial Agents and Chemotherapy”, 52 (7), 2008, s. 2673–2676, DOI: 10.1128/AAC.01596-07, PMID: 18443124, PMCID: PMC2443878 [dostęp 2024-05-05] (ang.).
U.U. Theuretzbacher U.U., Pharmacokinetics/pharmacodynamics of echinocandins, „European Journal of Clinical Microbiology and Infectious Diseases”, 23 (11), 2004, s. 805–812, DOI: 10.1007/s10096-004-1228-z, PMID: 15490294 [dostęp 2024-05-05] (ang.).
David S.D.S. Krause David S.D.S. i inni, Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia, „Antimicrobial Agents and Chemotherapy”, 48 (6), 2004, s. 2021–2024, DOI: 10.1128/AAC.48.6.2021-2024.2004, PMID: 15155194, PMCID: PMC415613 [dostęp 2024-05-05] (ang.).
M.A.M.A. Pfaller M.A.M.A. i inni, Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis, „Antimicrobial Agents and Chemotherapy”, 49 (11), 2005, s. 4795–4797, DOI: 10.1128/AAC.49.11.4795-4797.2005, PMID: 16251335, PMCID: PMC1280139 [dostęp 2024-05-05] (ang.).
Jennifer NielsenJ.N. Kahn Jennifer NielsenJ.N. i inni, Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase, „Antimicrobial Agents and Chemotherapy”, 51 (5), 2007, s. 1876–1878, DOI: 10.1128/AAC.00067-07, PMID: 17325225, PMCID: PMC1855530 [dostęp 2024-05-05] (ang.).

drugbank.ca

Anidulafungin, [w:] DrugBank [online], University of Alberta, DB00362 (ang.).

nih.gov

ncbi.nlm.nih.gov

H.H. Hof H.H., A.A. Dietz A.A., Antifungal activity of anidulafungin, a product of Aspergillus nidulans, against Aspergillus nidulans, „International Journal of Antimicrobial Agents”, 33 (3), 2009, s. 285–286, DOI: 10.1016/j.ijantimicag.2008.08.022, PMID: 19026523 [dostęp 2024-05-05] (ang.).
M.A.M.A. Pfaller M.A.M.A. i inni, In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole, „Journal of Clinical Microbiology”, 43 (11), 2005, s. 5425–5427, DOI: 10.1128/JCM.43.11.5425-5427.2005, PMID: 16272464, PMCID: PMC1287823 [dostęp 2024-05-05] (ang.).
Annette C.A.C. Reboli Annette C.A.C. i inni, Anidulafungin versus fluconazole for invasive candidiasis, „The New England Journal of Medicine”, 356 (24), 2007, s. 2472–2482, DOI: 10.1056/NEJMoa066906, PMID: 17568028 [dostęp 2024-05-05] (ang.).
Melissa J.M.J. Jacobson Melissa J.M.J. i inni, In vitro activity of anidulafungin against Candida albicans biofilms, „Antimicrobial Agents and Chemotherapy”, 52 (6), 2008, s. 2242–2243, DOI: 10.1128/AAC.00211-08, PMID: 18391031, PMCID: PMC2415795 [dostęp 2024-05-05] (ang.).
BharatB. Damle BharatB., MartinM. Stogniew MartinM., JamesJ. Dowell JamesJ., Pharmacokinetics and tissue distribution of anidulafungin in rats, „Antimicrobial Agents and Chemotherapy”, 52 (7), 2008, s. 2673–2676, DOI: 10.1128/AAC.01596-07, PMID: 18443124, PMCID: PMC2443878 [dostęp 2024-05-05] (ang.).
U.U. Theuretzbacher U.U., Pharmacokinetics/pharmacodynamics of echinocandins, „European Journal of Clinical Microbiology and Infectious Diseases”, 23 (11), 2004, s. 805–812, DOI: 10.1007/s10096-004-1228-z, PMID: 15490294 [dostęp 2024-05-05] (ang.).
David S.D.S. Krause David S.D.S. i inni, Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia, „Antimicrobial Agents and Chemotherapy”, 48 (6), 2004, s. 2021–2024, DOI: 10.1128/AAC.48.6.2021-2024.2004, PMID: 15155194, PMCID: PMC415613 [dostęp 2024-05-05] (ang.).
M.A.M.A. Pfaller M.A.M.A. i inni, Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis, „Antimicrobial Agents and Chemotherapy”, 49 (11), 2005, s. 4795–4797, DOI: 10.1128/AAC.49.11.4795-4797.2005, PMID: 16251335, PMCID: PMC1280139 [dostęp 2024-05-05] (ang.).
Jennifer NielsenJ.N. Kahn Jennifer NielsenJ.N. i inni, Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase, „Antimicrobial Agents and Chemotherapy”, 51 (5), 2007, s. 1876–1878, DOI: 10.1128/AAC.00067-07, PMID: 17325225, PMCID: PMC1855530 [dostęp 2024-05-05] (ang.).